Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 46 AL 60

Probing the secrets of Alzheimer's disease using human-induced pluripotent stem cell technology

Goldstein LS, Reyna S, Woodruff G.

Neurotherapeutics. 2015 Jan;12(1):121-5. doi: 10.1007/s13311-014-0326-6.

Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies

Boncoraglio GB, Piazza F, Savoiardo M, Farina L, DiFrancesco JC, Prioni S, Tagliavini F, Parati EA, Giaccone G.

J Alzheimers Dis. 2015;45(2):363-7. doi: 10.3233/JAD-142376.

A phase II trial of tideglusib in Alzheimer's disease

Lovestone S, Boada M, Dubois B, Hüll M, Rinne JO, Huppertz HJ, Calero M, Andrés MV, Gómez-Carrillo B, León T, del Ser T; ARGO investigators.

J Alzheimers Dis. 2015;45(1):75-88. doi: 10.3233/JAD-141959.

Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease

Kim TW.

Neurotherapeutics. 2015 Jan;12(1):132-42. doi: 10.1007/s13311-014-0325-7.

Preventing Alzheimer's disease by means of natural selection

Demetrius LA, Driver JA.

J R Soc Interface. 2015 Jan 6;12(102):20140919. doi: 10.1098/rsif.2014.0919.

Dantrolene, a treatment for Alzheimer disease?

Liang L, Wei H.

Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):1-5. doi: 10.1097/WAD.0000000000000076.

[Multifunctional ligands--a new approach in the search for drugs against multi-factorial diseases]

Wichur T, Malawska B.

Postepy Hig Med Dosw (Online). 2015 Jan 2;69:1423-34.

Principles and management of neuropsychiatric symptoms in Alzheimer's dementia

Nowrangi MA, Lyketsos CG, Rosenberg PB.

Alzheimers Res Ther. 2015 Jan 29;7(1):12. doi: 10.1186/s13195-015-0096-3.

Critical analysis of Alzheimer's amyloid-beta toxicity to mitochondria

Kaminsky YG, Tikhonova LA, Kosenko EA.

Front Biosci (Landmark Ed). 2015 Jan 1;20(1):173-97. doi: 10.2741/4304.

Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction?

Peric A, Annaert W.

Acta Neuropathol. 2015 Mar;129(3):363-81. doi: 10.1007/s00401-014-1379-7. Epub 2015 Jan 3.

Brain metabolism and Alzheimer's disease: the prospect of a metabolite-based therapy

Thomas SC, Alhasawi A, Appanna VP, Auger C, Appanna VD.

J Nutr Health Aging. 2015 Jan;19(1):58-63. doi: 10.1007/s12603-014-0511-7.

A novel prescription for Alzheimer's disease: targeting hypercoagulable states

Maiese K.

Curr Neurovasc Res. 2015;12(1):1-3. doi: 10.2174/1567202612666150107162329.

Optimising the cutoffs of cognitive screening instruments in pragmatic diagnostic accuracy studies: maximising accuracy or the Youden index?

Larner AJ.

Dement Geriatr Cogn Disord. 2015;39(3-4):167-75. doi: 10.1159/000369883. Epub 2015 Jan 6.

Synaptic therapy in Alzheimer's disease: a CREB-centric approach

Teich AF, Nicholls RE, Puzzo D, Fiorito J, Purgatorio R, Fa' M, Arancio O.

Neurotherapeutics. 2015 Jan;12(1):29-41. doi: 10.1007/s13311-014-0327-5.

Hsp90 interaction with clients

Karagöz GE, Rüdiger SG.

Trends Biochem Sci. 2015 Feb;40(2):117-25. doi: 10.1016/j.tibs.2014.12.002. Epub 2015 Jan 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias